Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to bisphosphonate therapy

Journal of the American Dental Association

Volumn 140, Issue 10, 2009, Pages 1259-1265

  Sedghizadeh, Parish P ^a   Kumar, Satish K S ^a   Gorur, Amita ^a   Schaudinn, Christoph ^a   Shuler, Charles F ^a,b,c   Costerton, J William ^a,c,d  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c ALLEGHENY GENERAL HOSPITAL   (United States)

^d ALLEGHENY SINGER RESEARCH INSTITUTE   (United States)

Author keywords

Biofilms; Bisphosphonates; Jawbones; Osteomyelitis; Osteonecrosis

Indexed keywords

EID: 73049108275     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2009.0049     Document Type: Article

References (31)

1. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002;15(2):167-193.
2. Patel R. Biofilms and antimicrobial resistance. Clin Orthop Relat Res 2005; (437):41-47.
3. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999;284(5418):1318-1322.
4. Ehrlich GD, Stoodley P, Kathju S, et al. Engineering approaches for the detection and control of orthopaedic biofilm infections. Clin Orthop Relat Res 2005; (437):59-66.
5. Costerton JW. Biofilm theory can guide the treatment of devicerelated orthopaedic infections. Clin Orthop Relat Res 2005; (437):7-11.
6. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet 2001;358(9276):135-138.
7. McDowell A, Patrick S. Evaluation of nonculture methods for the detection of prosthetic hip biofilms. Clin Orthop Relat Res 2005; (437):74-82.
8. Lew DP, Waldvogel FA. Osteomyelitis. Lancet 2004;364(9431):369-379.
9. Jauregui LE, Senour CL. Chronic osteomyelitis. In: Jauregui LE, ed. Diagnosis and Management of Bone Infections. New York City: Marcel Dekker; 1995:37-108. "http://books.google.com/books?id=L-PUT6Dlzo4C&pg= PR5&lpg=PR5&dq=Diagnosis+and+Ma nagement+of+Bone+Infections+Marcel+Dekker&source=bl&ots=hizqp SjGqd&sig=wg0Ky7oI8QKU5AEepiQXBahOcoY&hl=en&ei=rq6FSo0sh tr5BteHhbsJ&sa=X&oi=book-result&ct=result&resnum=1=onepage &q=&f=false". Accessed Aug. 20, 2009.
10. Lazzarini L, Mader JT, Calhoun JH. Osteomyelitis in long bones. J Bone Joint Surg Am 2004;86-A (10):2305-2318.
11. May JW Jr, Jupiter JB, Gallico GG 3rd, Rothkopf DM, Zingarelli P. Treatment of chronic traumatic bone wounds: microvascular free tissue transfer-a 13-year experience in 96 patients. Ann Surg 1991;214(3):241-250; discussion 250-252.
12. Reid IR. Osteonecrosis of the jaw: who gets it, and why? Bone 2009;44(1):4-10.
13. Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 2002;32(2):94-124.
14. Ruggiero SL, Fantasia J, Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102(4):433-441.
15. Migliorati CA, Siegel MA, Elting LS. Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment (published correction appears in Lancet Oncol 2006;7[7]:533). Lancet Oncol 2006;7(6):508-514.
16. Woo SB, Hellstein JW, Kalmar JR. Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws (published correction appears in Ann Intern Med 2006;145[3]:235). Ann Intern Med 2006;144(10):753-761.
17. Sedghizadeh PP, Kumar SK, Gorur A, Schaudinn C, Shuler CF, Costerton JW. Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy. J Oral Maxillofac Surg 2008;66(4):767-775.
18. Gorby YA, Yanina S, McLean JS, et al. Electrically conductive bacterial nanowires produced by Shewanella oneidensis strain MR-1 and other microorganisms. Proc Natl Acad Sci U S A 2006;103(30):11358-11363.
19. Price JD, Craig GT, Martin MV. Actinomyces viscosus in association with chronic osteomyelitis of the mandible. Br Dent J 1982;153(9):331-333.
20. Walker S, Middelkamp JN, Sclaroff A. Mandibular osteomyelitis caused by Actinomyces israelii. Oral Surg Oral Med Oral Pathol 1981;51(3):243-244.
21. Badros A, Weikel D, Salama A, et al. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol 2006;24(6):945-952.
22. Hansen T, Kunkel M, Springer E, et al. Actinomycosis of the jaws: histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis. Virchows Arch 2007;451(6):1009-1017.
23. Dannemann C, Grätz KW, Zwahlen R. Clinical experiences with bisphosphonate induced osteochemonecrosis of the jaws. Swiss Med Wkly 2006;136(31-32):504-509.
24. Veeh RH, Shirtliff ME, Petik JR, et al. Detection of Staphylococcus aureus biofilm on tampons and menses components. J Infect Dis 2003;188(4):519-530.
25. Wade W. Unculturable bacteria: the uncharacterized organisms that cause oral infections. J R Soc Med 2002;95(2):81-83.
26. Duguid IG, Evans E, Brown MR, Gilbert P. Effect of biofilm culture upon the susceptibility of Staphylococcus epidermidis to tobramycin. J Antimicrob Chemother 1992;30(6):803-810.
27. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003;61(9):1115-1117.
28. Henderson B, Nair SP. Hard labour: bacterial infection of the skeleton. Trends Microbiol 2003;11(12):570-577.
29. Harrington DJ. Bacterial collagenases and collagen-degrading enzymes and their potential role in human disease. Infect Immun 1996;64(6):1885-1891.
30. Nelson CL, McLaren AC, McLaren SG, Johnson JW, Smeltzer MS. Is aseptic loosening truly aseptic? Clin Orthop Relat Res 2005; (437):25-30.
31. Ripamonti CI, Maniezzo M, Campa T, et al. Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates: the experience of the National Cancer Institute of Milan. Ann Oncol 2009;20(1):137-145.